Literature DB >> 3355762

Validation of the fluorescent dye Hoechst 33342 as a vascular space marker in tumours.

K A Smith1, S A Hill, A C Begg, J Denekamp.   

Abstract

The DNA-binding fluorescent dye Hoechst 33342 (H33342) has been used in a series of investigations of the vascular parameters of two murine tumours. This dye has been shown, to have a short half-life in the circulation (T1/2 less than 2 min), but is stably bound for at least 2 h after it enters cells. It can be used in morphometric studies on frozen sections to determine the effective vascular volume, the capillary fraction and the size distribution of blood vessels in each tumour. These latter two parameters cannot be deduced from the less labour intensive techniques using radioactive isotopes. The effective vascular volume perfused in 1 min by H33342 was compared with the volume perfused in 30 min with 51Cr labelled erythrocytes. Similar volumes were estimated with the two techniques in a murine carcinoma and in a sarcoma. Both techniques showed that the vascular volume decreased in larger tumours. The H33342 analysis of vessel size showed the decrease in capillary vessels in the carcinomas was even greater, falling from 70% in small tumours to 20% in larger tumours. The deteriorating vascular network in larger tumours is associated with an increasing fraction of necrotic tissue. Experiments in which the isotopes and dye were co-injected suggest that at 40 mgkg-1 the dye may rapidly lead to a partial shutdown of the tumour vascular bed. This is less marked with 20 mg kg-1. In spite of this effect there is in general a close correlation between the volumes perfused by labelled red blood cells and the fluorescent dye.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3355762      PMCID: PMC2246513          DOI: 10.1038/bjc.1988.54

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  27 in total

1.  Regional blood flow by fractional distribution of indicators.

Authors:  L A SAPIRSTEIN
Journal:  Am J Physiol       Date:  1958-04

2.  Effect of x irradiation on vascularity of normal tissues and experimental tumor.

Authors:  C W Song; S H Levitt
Journal:  Radiology       Date:  1970-02       Impact factor: 11.105

3.  Alteration of binding of the supravital dye Hoechst 33342 to human leukemic cells by adriamycin.

Authors:  H D Preisler
Journal:  Cancer Treat Rep       Date:  1978-09

4.  Patterns of vasculature in two pairs of related fibrosarcomas in the rat and their relation to tumour responses to single large doses of radiation.

Authors:  P Falk
Journal:  Eur J Cancer       Date:  1978-03       Impact factor: 9.162

5.  Analysis and sorting of living cells according to deoxyribonucleic acid content.

Authors:  D J Arndt-Jovin; T M Jovin
Journal:  J Histochem Cytochem       Date:  1977-07       Impact factor: 2.479

6.  Vascular structure of the C3H mammary carcinoma, the B16 melanoma and the Lewis lung carcinoma in syngeneic, conventional mice and congenitally athymic mice.

Authors:  O V Solesvik; E K Rofstad; T Brustad
Journal:  Eur J Cancer Clin Oncol       Date:  1985-04

7.  The gross response of an experimental tumour to single doses of x-rays.

Authors:  R H Thomlinson; E A Craddock
Journal:  Br J Cancer       Date:  1967-03       Impact factor: 7.640

8.  Vascular structure of five human malignant melanomas grown in athymic nude mice.

Authors:  O V Solesvik; E K Rofstad; T Brustad
Journal:  Br J Cancer       Date:  1982-10       Impact factor: 7.640

9.  The effects of melphalan and misonidazole on the vasculature of a murine sarcoma.

Authors:  J C Murray; V Randhawa; J Denekamp
Journal:  Br J Cancer       Date:  1987-03       Impact factor: 7.640

10.  Endothelial-cell proliferation in experimental tumours.

Authors:  J Denekamp; B Hobson
Journal:  Br J Cancer       Date:  1982-11       Impact factor: 7.640

View more
  29 in total

1.  Treatment of experimental brain tumors with trombospondin-1 derived peptides: an in vivo imaging study.

Authors:  A Bogdanov; E Marecos; H C Cheng; L Chandrasekaran; H C Krutzsch; D D Roberts; R Weissleder
Journal:  Neoplasia       Date:  1999-11       Impact factor: 5.715

2.  The vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor cediranib (Recentin; AZD2171) inhibits endothelial cell function and growth of human renal tumor xenografts.

Authors:  Dietmar W Siemann; W D Brazelle; Juliane M Jürgensmeier
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-03-01       Impact factor: 7.038

3.  Effects of exercise training on tumor hypoxia and vascular function in the rodent preclinical orthotopic prostate cancer model.

Authors:  Danielle J McCullough; Linda M-D Nguyen; Dietmar W Siemann; Bradley J Behnke
Journal:  J Appl Physiol (1985)       Date:  2013-10-31

4.  Multichannel imaging to quantify four classes of pharmacokinetic distribution in tumors.

Authors:  Sumit Bhatnagar; Emily Deschenes; Jianshan Liao; Cornelius Cilliers; Greg M Thurber
Journal:  J Pharm Sci       Date:  2014-07-21       Impact factor: 3.534

5.  Antiangiogenic, antitumoural and antimetastatic effects of two distamycin A derivatives with anti-HIV-1 Tat activity in a Kaposi's sarcoma-like murine model.

Authors:  L Possati; D Campioni; F Sola; L Leone; L Ferrante; C Trabanelli; M Ciomei; M Montesi; R Rocchetti; S Talevi; S Bompadre; A Caputo; G Barbanti-Brodano; A Corallini
Journal:  Clin Exp Metastasis       Date:  1999       Impact factor: 5.150

6.  Monitoring the Vascular Response and Resistance to Sunitinib in Renal Cell Carcinoma In Vivo with Susceptibility Contrast MRI.

Authors:  Simon P Robinson; Jessica K R Boult; Naveen S Vasudev; Andrew R Reynolds
Journal:  Cancer Res       Date:  2017-05-31       Impact factor: 12.701

7.  Differential uptake of systemic fluorochrome Hoechst 33342 in lung and liver metastasis of B16 melanoma.

Authors:  E Hilario; E Rodeño; J Simón; F J Alvarez; S F Aliño
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992

8.  Distinct role of fibroblast growth factor-2 and vascular endothelial growth factor on tumor growth and angiogenesis.

Authors:  Raffaella Giavazzi; Barbara Sennino; Daniela Coltrini; Angela Garofalo; Romina Dossi; Roberto Ronca; Maria Pia Molinari Tosatti; Marco Presta
Journal:  Am J Pathol       Date:  2003-06       Impact factor: 4.307

9.  Measles virus entry through the signaling lymphocyte activation molecule governs efficacy of mantle cell lymphoma radiovirotherapy.

Authors:  Tanner S Miest; Marie Frenzke; Roberto Cattaneo
Journal:  Mol Ther       Date:  2013-08-05       Impact factor: 11.454

10.  Effect of antivascular endothelial growth factor treatment on the intratumoral uptake of CPT-11.

Authors:  H Wildiers; G Guetens; G De Boeck; E Verbeken; B Landuyt; W Landuyt; E A de Bruijn; A T van Oosterom
Journal:  Br J Cancer       Date:  2003-06-16       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.